/
PBIGF
$0.13-$0.02 (-10.20%)prev close
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.10 – $0.35
13% from low
Exchange
OTC Link
OS
Price (6 mo)
Loading chart…
Change$-0.80
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.7M | $3.0M | $0 | $20.6K | $79.2K | $46.8K | $65.8K | $52.1K |
| Cost of revenue | $15.4K | $8.3K | $213.1K | $99.1K | $143.8K | $18.8K | $9.0K | $72.0K |
| Gross profit | $2.7M | $3.0M | −$213.0K | −$78.6K | −$64.5K | $27.9K | $56.8K | −$19.9K |
| Gross margin | 99.4% | 99.7% | — | -382.4% | -81.4% | 59.7% | 86.3% | -38.2% |
| R&D | $6.6M | $7.9M | $12.8M | $33.5M | $39.0M | $52.7M | $58.3M | $17.7M |
| Operating income | −$8.9M | −$8.7M | −$17.0M | −$43.2M | −$47.9M | −$60.1M | −$65.2M | −$22.9M |
| EBITDA | −$8.9M | −$9.0M | −$15.7M | −$43.1M | −$46.8M | −$59.9M | −$64.5M | −$25.2M |
| Net income | −$6.2M | −$15.6M | −$12.3M | −$34.3M | −$39.3M | −$51.9M | −$58.7M | −$18.8M |
| Net margin | -230.7% | -523.7% | — | -166895.4% | -49543.1% | -111013.7% | -89138.3% | -36014.5% |
| EPS (diluted) | -0.05 | -0.11 | -0.06 | -0.16 | -0.16 | -0.18 | -0.20 | -0.06 |
Annual figures · source: Financial Modeling Prep
Analyst estimates (consensus)
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $3M | $-0.09 | $-0.09–$-0.09 | 1 |
| 2027 | $3M | $-0.09 | $-0.09–$-0.09 | 1 |
| 2028 | $337M | $0.19 | $0.19–$0.19 | 1 |
Forward consensus · source: Financial Modeling Prep
DCF fair valuemodel estimate
Intrinsic value
$0.04
Price
$0.13
Implied downside
-67%
Peer comparison
PARADIGM BIOPHARMACEUTICL
PARADIGM BIOPHARMACEUTICL
Held by traders on TradeandTell
No one on the platform currently holds PBIGF.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in PBIGF as of their last filing.
Insider activity (SEC Form 4)
Stock splits
| Execution date | Ratio |
|---|---|
| 2025-02-07 | 5-for-4 |
Recent trades on TradeandTell
No one on the platform has traded PBIGF yet.